Severe cysticercal meningitis: clinical and imaging characteristics
- PMID: 20065006
- PMCID: PMC2803520
- DOI: 10.4269/ajtmh.2010.09-0347
Severe cysticercal meningitis: clinical and imaging characteristics
Abstract
In disease-endemic areas, severe cysticercal meningitis (SCM) is characterized by intense inflammatory cerebrospinal fluid (CSF) and negative bacterial and fungal cultures. There have been no systematic studies of SCM. We characterized patients with SCM and compare them with neurocysticercosis (NC) patients with mild CSF abnormalities by conducting a nine-year retrospective review at a neurological referral center. Two groups of patients were compared: group A, those with severe CSF pleocytosis > 1,000 cells/mm(3) (n = 12), and group B, those with CSF pleocytosis <or= 1,000 cells/mm(3) (n = 126). All patients had positive CSF results in an enzyme-linked immunosorbent assay for cysticercal antigens and negative CSF cultures for bacteria, fungi, and mycobacteria. Intracranial hypertension, meningeal signs, CSF hypoglycorrachia, and a longer clinical course of NC were more frequently seen in group A. It is likely that SCM often goes unrecognized. Its correct identification may reduce morbidity and risks of unnecessary surgery in patients with chronic NC and CSF shunts.
Similar articles
-
Assessment of antibody responses to antigens of Mycobacterium tuberculosis and Cysticercus cellulosae in cerebrospinal fluid of chronic meningitis patients for definitive diagnosis as TBM/NCC by passive hemagglutination and immunoblot assays.FEMS Immunol Med Microbiol. 2002 Mar 25;33(1):57-61. doi: 10.1111/j.1574-695X.2002.tb00573.x. FEMS Immunol Med Microbiol. 2002. PMID: 11985970
-
Influence of the cerebrospinal fluid laboratory parameters in the ELISA test for neurocysticercosis using a total cysticerci antigen.Arq Neuropsiquiatr. 2006 Mar;64(1):55-9. doi: 10.1590/s0004-282x2006000100012. Epub 2006 Apr 5. Arq Neuropsiquiatr. 2006. PMID: 16622554
-
Evaluation of enzyme linked immunosorbent--assay for the detection of anticysticercus antibodies in cerebrospinal fluid from patients with neurocysticercosis.J Hyg Epidemiol Microbiol Immunol. 1992;36(2):181-90. J Hyg Epidemiol Microbiol Immunol. 1992. PMID: 1512454
-
A systematic review of cases of meningitis in the absence of cerebrospinal fluid pleocytosis on lumbar puncture.BMC Infect Dis. 2019 Aug 5;19(1):692. doi: 10.1186/s12879-019-4204-z. BMC Infect Dis. 2019. PMID: 31382892 Free PMC article.
-
[A cerebrospinal fluid syndrome in neurocysticercosis].Arq Neuropsiquiatr. 1987 Sep;45(3):261-75. doi: 10.1590/s0004-282x1987000300006. Arq Neuropsiquiatr. 1987. PMID: 2449880 Review. Portuguese.
Cited by
-
New diagnostic criteria for neurocysticercosis: Reliability and validity.Ann Neurol. 2016 Sep;80(3):434-42. doi: 10.1002/ana.24732. Epub 2016 Aug 13. Ann Neurol. 2016. PMID: 27438337 Free PMC article.
-
Extraparenchymal neurocysticercosis in the United States.Am J Med Sci. 2012 Jul;344(1):79-82. doi: 10.1097/MAJ.0b013e31823e6565. Am J Med Sci. 2012. PMID: 22222333 Free PMC article. Review.
-
Extraparenchymal neurocysticercosis in the United States: a case report.J Med Case Rep. 2011 Aug 9;5:359. doi: 10.1186/1752-1947-5-359. J Med Case Rep. 2011. PMID: 21827687 Free PMC article.
-
Diagnosis and treatment of neurocysticercosis.Nat Rev Neurol. 2011 Sep 13;7(10):584-94. doi: 10.1038/nrneurol.2011.135. Nat Rev Neurol. 2011. PMID: 21912406 Free PMC article. Review.
-
Parasitic diseases of the central nervous system: lessons for clinicians and policy makers.Expert Rev Neurother. 2016;16(4):401-14. doi: 10.1586/14737175.2016.1155454. Epub 2016 Mar 4. Expert Rev Neurother. 2016. PMID: 26894629 Free PMC article. Review.
References
-
- Fleury A, Dessein A, Preux PM, Dumas M, Tapia G, Larralde C, Sciutto E. Symptomatic human neurocysticercosis: age, sex and exposure factors relating with disease heterogeneity. J Neurol. 2004;251:830–830. - PubMed
-
- Bandres JA, White AC, Samo T, Murphy EC, Harris RL. Extraparenchymal neurocysticercosis: report of five cases and review of literature on management. Clin Infect Dis. 1992;15:799–799. - PubMed
-
- Venkataraman S, Roy AK, Dhamija RM, Sanchetee PC. Cysticercal meningoencephalitis: clinical presentation and autopsy findings. J Assoc Physicians India. 1990;38:763–763. - PubMed
-
- Singh G. Neurocysticercosis in the South-Central America and the Indian subcontinent. A comparative evaluation. Arq Neuropsiquiatr. 1997;55:349–349. - PubMed
-
- Vaz AJ, Hanashiro AS, Chieffi PP, Ferreira AW. Frequency of patients with anti-cysticercus cellulosae antibodies in 5 municipalities of state of São Paulo. Rev Soc Bas Med Trop. 1990;23:97–97. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources